D. Lorne Tyrrell - Concepedia

Author

D. Lorne Tyrrell

Also Known As

D L Tyrrell, D Lorne J Tyrrell, D Lorne J. Tyrrell, D Lorne Tyrrell, D TYRRELL, D Tyrrell, D. L. J. Tyrrell, D. L. TYRRELL, D. L. Tyrrell, D. Lorne J Tyrrell

273

Publications

10.1K

Citations

H-Index

179

Concepts

All Affiliations

University of Alberta KMT Hepatech (Canada)University of Calgary

About

D. Lorne Tyrrell is an author at University of Alberta specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	71	3.6K
2	Natural Sciences	15	21	735
3	Engineering	6	6	154
4	Health Sciences	2	2	45
5	Public Health	2	2	28

D. Lorne Tyrrell

158

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Nature Communications	2020	456
Mutation in Hbv Rna–Dependent Dna Polymerase Confers Resistance to Lamivudine In Vivo Graham Tipples, Karl P. Fischer, Vincent G. Bain, Hepatology	1996	442
Molecular Diagnosis of COVID-19: Challenges and Research Needs Wei Feng, Ashley M. Newbigging, Connie Le, Analytical Chemistry Polymerase Chain ReactionMolecular DiagnosisMolecular Diagnostic TechniquesDiagnostic VirologyViral Diagnostics	2020	384
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor Olusegun O. Onabajo, Abdul Rouf Banday, Megan L. Stanifer, Nature Genetics	2020	261
Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology Bo Pang, Jingyang Xu, Yan‐Ming Liu, Analytical Chemistry	2020	247
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Jordan J. Feld, Christopher Kandel, Mia J. Biondi, The Lancet Respiratory Medicine	2021	235
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery Carrie S.W. Chong, Min Cao, Winnie W. Wong, Journal of Controlled Release VaccinationCross-protectionVaccine DevelopmentImmunologyVaccine Delivery	2004	190
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans John Lok Man Law, Chao Chen, Jason Wong, PLoS ONE VaccinationVaccine DevelopmentHepatitis CHepatitis C VirusViral Hepatitis	2013	174
IFITm1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry Courtney Wilkins, Jessica Woodward, Daryl Lau, Hepatology	2012	154
Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses Mireille R. St.Vincent, Che C. Colpitts, Alexey V. Ustinov, Proceedings of the National Academy of Sciences	2010	154

Page 1